These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 38087384)

  • 1. Hypertension in Cardio-Oncology Clinic: an update on etiology, assessment, and management.
    Askarinejad A; Alizadehasl A; Jolfayi AG; Adimi S
    Cardiooncology; 2023 Dec; 9(1):46. PubMed ID: 38087384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hypertension and cancer : Dangerous Liaisons].
    Duvillier P
    Ann Cardiol Angeiol (Paris); 2022 Nov; 71(5):317-320. PubMed ID: 36075765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Therapy-Related Hypertension: A Scientific Statement From the American Heart Association.
    Cohen JB; Brown NJ; Brown SA; Dent S; van Dorst DCH; Herrmann SM; Lang NN; Oudit GY; Touyz RM;
    Hypertension; 2023 Mar; 80(3):e46-e57. PubMed ID: 36621810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention.
    Perry TR; Roberts ML; Sunkara B; Maddula R; McLeish T; Gomez J; Lucas J; Rayan D; Patel S; Liang M; Bosnjak ZJ; Brown SA
    Curr Oncol Rep; 2021 May; 23(7):77. PubMed ID: 33937943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Team-Based Approach to Management of Hypertension Associated with Angiogenesis Inhibitors.
    Patel S; Dushenkov A; Jungsuwadee P; Krishnaswami A; Barac A
    J Cardiovasc Transl Res; 2020 Jun; 13(3):463-477. PubMed ID: 32430701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A virtual-hybrid approach to launching a cardio-oncology clinic during a pandemic.
    Brown SA; Patel S; Rayan D; Zaharova S; Lin M; Nafee T; Sunkara B; Maddula R; MacLeod J; Doshi K; Meskin J; Marks D; Saucedo J
    Cardiooncology; 2021 Jan; 7(1):2. PubMed ID: 33441188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etiology and management of hypertension in patients with cancer.
    Mohammed T; Singh M; Tiu JG; Kim AS
    Cardiooncology; 2021 Apr; 7(1):14. PubMed ID: 33823943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society.
    Lyon AR; Dent S; Stanway S; Earl H; Brezden-Masley C; Cohen-Solal A; Tocchetti CG; Moslehi JJ; Groarke JD; Bergler-Klein J; Khoo V; Tan LL; Anker MS; von Haehling S; Maack C; Pudil R; Barac A; Thavendiranathan P; Ky B; Neilan TG; Belenkov Y; Rosen SD; Iakobishvili Z; Sverdlov AL; Hajjar LA; Macedo AVS; Manisty C; Ciardiello F; Farmakis D; de Boer RA; Skouri H; Suter TM; Cardinale D; Witteles RM; Fradley MG; Herrmann J; Cornell RF; Wechelaker A; Mauro MJ; Milojkovic D; de Lavallade H; Ruschitzka F; Coats AJS; Seferovic PM; Chioncel O; Thum T; Bauersachs J; Andres MS; Wright DJ; López-Fernández T; Plummer C; Lenihan D
    Eur J Heart Fail; 2020 Nov; 22(11):1945-1960. PubMed ID: 32463967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons learnt in the first year of an Australian pediatric cardio oncology clinic.
    Toro C; Felmingham B; Jhadav M; Celermajer DS; La Gerche A; O'Sullivan J; Kumar S; Mateos MK; Fulbright J; Govender D; Collier L; Cheung M; Eisenstat DD; Lange PW; Ayer J; Elliott DA; Conyers R
    Cardiooncology; 2023 Dec; 9(1):45. PubMed ID: 38062530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision cardio-oncology: understanding the cardiotoxicity of cancer therapy.
    Han X; Zhou Y; Liu W
    NPJ Precis Oncol; 2017; 1(1):31. PubMed ID: 29872712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension management in cardio-oncology.
    Essa H; Dobson R; Wright D; Lip GYH
    J Hum Hypertens; 2020 Oct; 34(10):673-681. PubMed ID: 32747676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF Receptor Inhibitor-Induced Hypertension: Emerging Mechanisms and Clinical Implications.
    Camarda N; Travers R; Yang VK; London C; Jaffe IZ
    Curr Oncol Rep; 2022 Apr; 24(4):463-474. PubMed ID: 35179707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertensive Cardiotoxicity in Cancer Treatment-Systematic Analysis of Adjunct, Conventional Chemotherapy, and Novel Therapies-Epidemiology, Incidence, and Pathophysiology.
    Chung R; Tyebally S; Chen D; Kapil V; Walker JM; Addison D; Ismail-Khan R; Guha A; Ghosh AK
    J Clin Med; 2020 Oct; 9(10):. PubMed ID: 33081013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial hypertension in patients under antineoplastic therapy: a systematic review.
    Katsi V; Magkas N; Georgiopoulos G; Athanasiadi E; Virdis A; Masi S; Kliridis P; Hatziyanni A; Tsioufis C; Tousoulis D
    J Hypertens; 2019 May; 37(5):884-901. PubMed ID: 30624368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which elderly patients should be considered for anti-hypertensive treatment? An evidence-based approach.
    Jackson R
    J Hum Hypertens; 1998 Sep; 12(9):607-13. PubMed ID: 9783489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Increases in Blood Pressure and Major Adverse Cardiovascular Events in Patients With Renal Cell Carcinoma and Thyroid Cancer Treated With VEGFR TKIs.
    Narayan V; Liu T; Song Y; Mitchell J; Sicks J; Gareen I; Sun L; Denduluri S; Fisher C; Manikowski J; Wojtowicz M; Vadakara J; Haas N; Margulies KB; Ky B
    J Natl Compr Canc Netw; 2023 Oct; 21(10):1039-1049.e10. PubMed ID: 37856199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.
    Pudil R; Mueller C; Čelutkienė J; Henriksen PA; Lenihan D; Dent S; Barac A; Stanway S; Moslehi J; Suter TM; Ky B; Štěrba M; Cardinale D; Cohen-Solal A; Tocchetti CG; Farmakis D; Bergler-Klein J; Anker MS; Von Haehling S; Belenkov Y; Iakobishvili Z; Maack C; Ciardiello F; Ruschitzka F; Coats AJS; Seferovic P; Lainscak M; Piepoli MF; Chioncel O; Bax J; Hulot JS; Skouri H; Hägler-Laube ES; Asteggiano R; Fernandez TL; de Boer RA; Lyon AR
    Eur J Heart Fail; 2020 Nov; 22(11):1966-1983. PubMed ID: 33006257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update of Targeted Therapy-Induced Hypertension: Basics for Non-Oncology Providers.
    Escalante CP; Lu M; Marten CA
    Curr Hypertens Rev; 2016; 12(2):112-20. PubMed ID: 26931476
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.